Galectin Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:GALT) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 8.58 M12.8 M7.7 M6.6 M3.5 M 30.6 M Cash from investing activities ————— — Cash from financing activities 10 M851 K012.94 M1.3 M 15.09 M Free cash flow 8.58 M12.8 M7.7 M6.6 M3.5 M 30.6 M

Notizie

갈락틴 테라퓨틱스 이사, 마크 루빈 사임

Galectin Therapeutics director Marc Rubin resigns from board

Galectin Therapeutics CFO, 23.3만 달러 상당 주식 매도

Galectin Therapeutics CFO sells $233k in shares

Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains

oracle, micron tech among market cap stock movers on friday

Galectin Therapeutics, FDA 피드백 후 주가 폭락

Galectin Therapeutics stock plummets after FDA feedback on drug

FDA provides feedback on Galectin’s belapectin development program

갈렉틴 테라퓨틱스 이사, 105만 달러 상당 주식 매도

갈렉틴 테라퓨틱스, 이사진 선임 및 주요 제안 승인

Clinical Progress Drives Galectin Shares Up Post-NAVIGATE Data (NASDAQ:GALT)